The Role and the Effect of Magnesium in Mental Disorders: A Systematic Review
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Introduction: Magnesium is an essential cation involved in many functions within the central nervous system, including transmission and intracellular signal transduction. Several studies have shown its usefulness in neurological and psychiatric diseases. Furthermore, it seems that magnesium levels are lowered in the course of several mental disorders, especially depression. Objectives: In this study, we wish to evaluate the presence of a relationship between the levels of magnesium and the presence of psychiatric pathology as well as the effectiveness of magnesium as a therapeutic supplementation. Methods: A systematic search of scientific records concerning magnesium in psychiatric disorders published from 2010 up to March 2020 was performed. We collected a total of 32 articles: 18 on Depressive Disorders (DD), four on Anxiety Disorders (AD), four on Attention Deficit Hyperactivity Disorder (ADHD), three on Autism Spectrum Disorder (ASD), one on Obsessive–Compulsive Disorder (OCD), one on Schizophrenia (SCZ) and one on Eating Disorders (ED). Results: Twelve studies highlighted mainly positive results in depressive symptoms. Seven showed a significant correlation between reduced plasma magnesium values and depression measured with psychometric scales. Two papers reported improved depressive symptoms after magnesium intake, two in association with antidepressants, compared to controls. No significant association between magnesium serum levels and panic or Generalized Anxiety Disorder (GAD) patients, in two distinct papers, was found. In two other papers, a reduced Hamilton Anxiety Rating Scale (HAM-A) score in depressed patients correlated with higher levels of magnesium and beneficial levels of magnesium in stressed patients was found. Two papers reported low levels of magnesium in association with ADHD. Only one of three papers showed lower levels of magnesium in ASD. ED and SCZ reported a variation in magnesium levels in some aspects of the disease. Conclusion: The results are not univocal, both in terms of the plasma levels and of therapeutic effects. However, from the available evidence, it emerged that supplementation with magnesium could be beneficial. Therefore, it is necessary to design ad hoc clinical trials to evaluate the efficacy of magnesium alone or together with other drugs (antidepressants) in order to establish the correct use of this cation with potential therapeutic effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942 · cited 1×
“Notably, the presence of many studies on depression is not surprising since the use of magnesium is mostly reserved to depressive disorders, because of its involvement in several core mechanisms of depressive physiopathology, including glutamatergic transmission in the limbic system and cerebral cortex [89], regulatio…”
BackgroundCipriani, A., Furukawa, T. A., Salanti, G., Chaimani, A., Atkinson, L. Z., Ogawa, Y., Leucht, S., Ruhe, H. G., Turner, E. H., Higgins, J. P. T., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32802-7 · Cited by 3,541
Estimating the true global burden of mental illness
Vigo, D., Thornicroft, G., & Atun, R. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00505-2 · Cited by 2,494
Global Burden of Disease and the Impact of Mental and Addictive Disorders
Rehm, J., & Shield, K. D. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-0997-0 · Cited by 1,388
Jahnen-Dechent, W., & Ketteler, M. (2012) · Clinical Kidney Journal · doi:10.1093/ndtplus/sfr163 · Cited by 1,054
Lassale, C., Batty, G. D., Baghdadli, A., Jacka, F., Sánchez-Villegas, A., Kivimäki, M., & Akbaraly, T. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0237-8 · Cited by 931
Leucht, S., Leucht, C., Huhn, M., Chaimani, A., Mavridis, D., Helfer, B., Samara, M., Rabaioli, M., Bächer, S., Cipriani, A., et al. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.16121358 · Cited by 542
Ehlert, U., Gaab, J., & Heinrichs, M. (2001) · Biological Psychology · doi:10.1016/s0301-0511(01)00092-8 · Cited by 510 · cited 1×
“Notably, the presence of many studies on depression is not surprising since the use of magnesium is mostly reserved to depressive disorders, because of its involvement in several core mechanisms of depressive physiopathology, including glutamatergic transmission in the limbic system and cerebral cortex [89], regulatio…”
BackgroundStructural and catalytic chemistry of magnesium-dependent enzymes
Cowan, J. A. (2002) · Biometals · doi:10.1023/a:1016022730880 · Cited by 428 · cited 1×
“Magnesium is essential to ensure the correct functioning of all human cells, neurons included; it is involved, among others processes, in hundreds of enzymatic reactions [28], intracellular transmission [29], myelination process [30], synapses formation and maintenance [31] as well as in the regulation of serotoninerg…”
BackgroundEfficacy of omega-3 PUFAs in depression: A meta-analysis
Liao, Y., Xie, B., Zhang, H., He, Q., Guo, L., Subramanieapillai, M., Fan, B., Lu, C., & McIntyre, R. S. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0515-5 · Cited by 404
Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review
Wang, S.-M., Han, C., Bahk, W.-M., Lee, S.-J., Patkar, A. A., Masand, P. S., & Pae, C.-U. (2018) · Chonnam Medical Journal · doi:10.4068/cmj.2018.54.2.101 · Cited by 299 · cited 1×
“Moreover, although the majority of drugs currently used to treat the more common psychiatric disorders have been proven to be effective by recent robust meta-analyses [4,5], most of the psychiatric pharmacotherapy must be continued for years (or even lifelong), bringing severe adverse side effects [6,7].”
BackgroundThe Effects of Magnesium Supplementation on Subjective Anxiety and Stress—A Systematic Review
Boyle, N., Lawton, C., & Dye, L. (2017) · Nutrients · doi:10.3390/nu9050429 · Cited by 162 · cited 1×
“Magnesium has also been studied, both in the form of enriched diet and supplementation at high doses, as an adjunct therapy for psychiatric disorders, in particular in anxiety [24] and mood [25] disorders.”
BackgroundLi, W., Yu, J., Liu, Y., Huang, X., Abumaria, N., Zhu, Y., Huang, X., Xiong, W., Ren, C., Liu, X.-G., et al. (2014) · Molecular Brain · doi:10.1186/s13041-014-0065-y · Cited by 146
Nutrition, immunological mechanisms and dietary immunomodulation in ADHD
Verlaet, A. A. J., Noriega, D. B., Hermans, N., & Savelkoul, H. F. J. (2014) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-014-0522-2 · Cited by 114 · cited 1×
“In recent years, some studies [87] have explored the association between micronutrient dietary intake and ADHD development.”
BackgroundRajizadeh, A., Mozaffari-Khosravi, H., Yassini-Ardakani, M., & Dehghani, A. (2017) · Nutrition · doi:10.1016/j.nut.2016.10.014 · Cited by 81
Hypomagnesaemia linked to depression: A systematic review and meta-analysis
Cheungpasitporn, W., Thongprayoon, C., Mao, M. A., Srivali, N., Ungprasert, P., Varothai, N., Sanguankeo, A., Kittanamongkolchai, W., & Erickson, S. B. (2015) · Internal Medicine Journal · doi:10.1111/imj.12682 · Cited by 57
The Association between Serum Magnesium Levels and Depression in an Adult Primary Care Population
Tarleton, E. K., Kennedy, A. G., Rose, G. L., Crocker, A., & Littenberg, B. (2019) · Nutrients · doi:10.3390/nu11071475 · Cited by 45
Cited by
Magnesium in Aging, Health and Diseases
Barbagallo, M., Veronese, N., & Dominguez, L. J. (2021) · Nutrients · doi:10.3390/nu13020463 · Cited by 359
The Role of Cholesterol and Fatty Acids in the Etiology and Diagnosis of Autism Spectrum Disorders
Esposito, C. M., Buoli, M., Ciappolino, V., Agostoni, C., & Brambilla, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073550 · Cited by 39
Self-citation
Metadata
- Authors
- Botturi, A., Ciappolino, V., Delvecchio, G., Boscutti, A., Viscardi, B., & Brambilla, P.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2020-06-03
- Volume
- 12
- Issue
- 6
- Pages
- 1661
- ISSN
- 2072-6643 (ISSN-L)
- OpenAlex
- W3033438882
- Cited by
- 163
- References
- 17
- FWCI
- 3.75
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.